232 related articles for article (PubMed ID: 1037259)
1. Pharmacology of dihydroxy-dibutylether, a specific choleretic drug.
Fregnan GB; Porta R
Arzneimittelforschung; 1976; 26(11):2116-24. PubMed ID: 1037259
[TBL] [Abstract][Full Text] [Related]
2. [Further observations on the gastrointestinal effects of 3,3'-dihydroxy-dibutyl ether].
Impicciatore M; Chiavarini M; Bertaccini G
Ateneo Parmense Acta Biomed; 1974 Jan-APR; 45(1-2):17-28. PubMed ID: 4219900
[No Abstract] [Full Text] [Related]
3. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution and excretion of a dihydroxydibutyl ether labelled with 14C in animals.
Porta R; Fregnan GB
Arzneimittelforschung; 1977; 27(1):118-22. PubMed ID: 403923
[TBL] [Abstract][Full Text] [Related]
5. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
Zwagemakers JM; Claassen V
Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
[TBL] [Abstract][Full Text] [Related]
8. General pharmacological properties of muroctasin.
Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
[TBL] [Abstract][Full Text] [Related]
9. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
10. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of moquizone, a new choleretic drug.
Setnikar I; Conti M; Guerci R
Arzneimittelforschung; 1972 Nov; 22(11):1894-903. PubMed ID: 4679063
[No Abstract] [Full Text] [Related]
12. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
13. [Spasmolytic effects of crebanine on isolated gallbladder and Oddi's sphincter in vitro].
Li H; Su C; Wang F
Zhongguo Zhong Yao Za Zhi; 1996 Jul; 21(7):434-6, inside backcover. PubMed ID: 9642399
[TBL] [Abstract][Full Text] [Related]
14. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
15. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112).
Märki F; Büch O; Delini-Stula A; Kraetz J; Petermann H; Radeke E; Schweizer A; Thomann P; Truog A
Arzneimittelforschung; 1984; 34(3):247-52. PubMed ID: 6539603
[TBL] [Abstract][Full Text] [Related]
16. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
17. [General pharmacology of aclacinomycin A (author's transl)].
Ohmori K; Hirano S; Hori S
Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
[TBL] [Abstract][Full Text] [Related]
18. [General pharmacological studies on tramadol, a potent analgetic agent (author's transl)].
Osterloh G; Friderichs E; Felgenhauer F; Günzler WA; Henmi Z; Kitano T; Nakamura M; Hayashi H; Ishii I
Arzneimittelforschung; 1978; 28(1a):135-51. PubMed ID: 305247
[TBL] [Abstract][Full Text] [Related]
19. General pharmacology of the new quinolone antibacterial agent levofloxacin.
Takasuna K; Kasai Y; Usui C; Takahashi M; Hirohashi M; Tamura K; Takayama S
Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
[TBL] [Abstract][Full Text] [Related]
20. General pharmacological properties of the main metabolite of flosequinan.
Fujita S; Ikezono K; Umezato M; Hosoki E; Toba Y; Ishikawa M; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
